Introduction
Risk stratification is an important step in the management of patients with left ventricular systolic dysfunction (LVSD) . Several studies have previously demonstrated that some systolic parameters of the right ventricle were independent predictors of cardiac survival. 1 -3 However, the analysis of right ventricular (RV) systolic function remains a difficult task. Radionuclide angiography is considered as the gold standard method for the determination of the right ventricular ejection fraction (RVEF). 1 -7 Because RVEF could not be easily determined by echocardiography, alternative methods have been studied. The two most common echocardiographic parameters of RV systolic function, currently used in clinical practice, are the tricuspid annular plane systolic excursion (TAPSE) 8 and the peak systolic tricuspid annular velocity (STr) measured on the RV lateral free wall by tissue Doppler. 9 To the best of our knowledge, no study has compared the prognostic value of radionuclide RVEF, TAPSE, and STr in a large group of stable patients with LVSD. We thus designed the present study in 527 patients with LVSD who underwent extensive prognostic evaluation including determination of radionuclide RVEF, TAPSE, and STr and in whom the long-term clinical outcome was assessed.
Methods
Between October 2003 and April 2008, we included consecutive patients who had an LV ejection fraction ≤45%, referred to our department for prognostic evaluation. Patients were included if they were ambulatory, clinically stable for at least 2 months without a recent (,3 months) acute coronary syndrome or coronary revascularization, without a recent implantation of a defibrillator (,3 months) or a biventricular pacing (,6 months). Patients received an optimal medical treatment (with maximal tolerated doses of renin inhibitors (angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers) and of beta-blockers without any dose modification in the last 3 months). Patients underwent a systematic coronarography to help define the aetiology of LVSD. Echocardiography was performed with a SONOS 5500 (Philips, Andover, MA, USA) with the determination of standard and Doppler parameters according to recommendations of the American Society of Echocardiography.
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Tricuspid annular plane systolic excursion and STr were determined as previously described. 8, 9 Left ventricular filling pressure was estimated by the sonographer (normal or increased) as recommended by the American Society of Echocardiography. 11 Pulmonary artery pressure was estimated as previously described. 12, 13 Patients without tricuspid regurgitation were assumed to have normal systolic pulmonary artery pressure (sPAP). Equilibrium radionuclide angiography was performed in the supine position with an ECAM camera (Siemens, Erlangen, Germany) after the injection of 740 MBq of technetium-99 m. Studies were acquired on a 64 × 64 matrix with 16 frames per cardiac cycle for a preset count of 5 000 000 cps, in the 458 left anterior oblique projection and the 308 right anterior oblique projection. The data for gas exchange during the cardiopulmonary exercise test were collected on a breath-by-breath basis using a computerized system (Sensormedics VMax, Yorba Linda, CA, USA). Peak oxygen consumption (VO 2 ) was defined as the highest average value during 20 s obtained during the last minute of exercise. Predicted value of maximal VO 2 was calculated using Wasserman's equation. 14 
Reproducibility of right ventricular parameters
The inter-observer variability of the measurements of RV variables was assessed in 30 patients (Supplementary material online, Table S1 ). We also performed a retrospective analysis from all our database. We selected 49 stable patients who had repeat radionuclide angiography within 6 months (5.2 + 0.1 months). These patients were selected if they were functionally stable, with similar treatment (drugs and doses) and similar LVEF. The selection was performed by two investigators who were blinded to the results of RVEF. From these 49 patients, 30 had TAPSE and STr measurements (Supplementary material online, Table S2 ). Bland and Altman graphs were shown in the Supplementary material online, Figures S1 and S2. Our results suggest that RVEF is reproducible and that STr is more reproducible than TAPSE.
Results

Clinical characteristics
We included 527 patients with a mean age of 56 + 13 years.
Major clinical characteristics are presented in Table 1 . Table 2 shows the treatment of our study population. Echocardiographic, radionuclide, and cardiopulmonary exercise test parameters and BNP concentrations are presented in Table 1 .
Regression analysis between right ventricular parameters Figure 1 shows the correlations between RVEF, TAPSE, and STr. There were weak correlations between RVEF and the two echoDoppler parameters; Figure 1 clearly shows the wide dispersion of individual data according to RVEF values. In contrast, TAPSE and STr were more closely correlated with a r ¼ 0.56.
Relationship between right ventricular ejection fraction and pulmonary pressures
Fifty-five patients had a right heart catheterization at the time of the RV evaluation. There was a correlation between RVEF and invasive sPAP (r ¼ 20.57) and between RVEF and pulmonary vascular resistance (PVR) (r ¼ 20.47). In these 55 patients, there was a good correlation between invasive sPAP and estimated sPAP by echocardiography (r ¼ 0.91). In the total study population, we found a similar correlation between estimated sPAP and RVEF (r ¼ 20.60).
Survival analysis
During a median duration of follow-up of 1268 days (802 -1830), there were 121 cardiovascular-related deaths (including 10 urgent transplantations and 6 urgent LVAD implantations), 39 noncardiovascular deaths, 25 non-urgent heart transplantations; 1 patient was lost to follow-up. All the alive patients were followed up for at least 1 year. Cardiovascular mortality rates were 8 and 13% at 1 and 2 years, respectively.
Univariate and bivariate analyses of right ventricular systolic parameters
Characteristics according to cardiac survival are presented in Table 1 . were not statistically significant. The best cut-off values were 37% for RVEF (sensitivity: 59%, specificity: 73%), 9.7 cm/s for STr (sensitivity: 62%, specificity: 64%), and 18.5 mm for TAPSE (sensitivity: 49%, specificity: 70%). Figure 3 shows survival curves in subgroups of patients divided according to these cut-off values. Table 4 shows independent predictors of cardiovascular-related death in the two multivariate models, one including TAPSE and the second one with STr. Right ventricular ejection fraction was an independent predictor of cardiovascular-related death in both models. The risk of cardiovascular-related death was almost double in patients with an RVEF ≤37% compared with patients with an RVEF .37%. In contrast to TAPSE, STr added an independent prognostic information to RVEF. Systolic pulmonary artery pressure was not selected as an independent predictor of cardiovascular-related death. The reclassification of subjects after adding RVEF in the model was estimated with the NRI: 8.9% of deceased patients and 1.3% of alive patients were correctly reclassified given a total NRI of 10.2% (z ¼ 2.58, P ¼ 0.001) (Supplementary material online, Table S3 ). The IDI after adding RVEF in the model was 11.3 + 0.5% (P ¼ 0.05). 
Multivariate analyses
Right ventricular systolic function and prognosis
Combination of right ventricular systolic parameters
We performed an analysis with the combination of RVEF and STr. Figure 4 shows survival curves of the study population divided into four subgroups of patients according to cut-off values of RVEF and of STr. Patients with an RVEF .37% and STr ≤9.7 cm/s had a survival rate of 92 and 88% at 1 and at 2 years, respectively, which was lower than the corresponding survival rates in patients with both RVEF and STr above the cut-off values (98 and 96%, respectively). Survival rates at 1 and at 2 years in patients with an RVEF ≤37% and STr .9.7 cm/s were 95 and 85%, respectively. The worse prognosis was observed in the subgroup of patients with both RVEF and STr, below the cut-off values (77 and 69% at 1 and at 2 years, respectively). Table 5 shows the results of the multivariate analysis with the combination of RVEF and STr in the model. This combination of RV systolic parameters was the most powerful predictor of cardiovascular-related death. The total NRI after adding both RVEF and STr in the model was 12.1% with 21% of deceased patients and 13.1% of alive patients correctly reclassified (z ¼ 2.6, P ¼ 0.009). The corresponding IDI was 12.4 + 0.5% (P ¼ 0.02).
Discussion
Our results demonstrate that RV systolic function remains a major independent predictor of cardiac survival in the modern era of LVSD management. Our data also show that, even in the context of a complete echocardiographic assessment, RVEF continues to be the most powerful RV systolic parameter for cardiac survival prediction. However, the determination of STr, in addition to RVEF, could improve risk stratification; the combination of both variables being the strongest independent prognostic indicator in multivariate models.
Correlation between right ventricular echoDoppler parameters and radionuclide right ventricular ejection fraction
Previous studies have reported that TAPSE or STr showed good correlations with RVEF. 8, 9, 16, 17 These analyses were performed in small series of selected patients (from 20 to 140 patients). Our study showed less favourable results. Figure 1 illustrates the wide variability between RVEF and the two echoDoppler parameters, demonstrating that, for an individual patient, it is not possible to predict RVEF by echoDoppler analysis. These results may be explained by the fact that both TAPSE and STr analyse longitudinal systolic function, 8, 9 while RVEF probably brings a more global information on RV systolic function since it does not really depend upon the complex geometrical shape of the RV.
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Correlation between radionuclide right ventricular ejection fraction and pulmonary pressures
Our population represents a stable group of ambulatory patients with LVSD. It is not possible to perform to all our patients a right heart catheterization in order to evaluate pulmonary pressure. We found, in a limited subgroup of patient, a correlation between either invasive sPAP or PVR and RVEF. However, we found a very good correlation between invasive sPAP and echographic estimated sPAP and a similar correlation between either estimated sPAP or invasive sPAP and RVEF. Our results suggest that an increase in sPAP, or an increase in PVR, plays a significant role in the level of RV systolic dysfunction.
Right ventricular parameters as predictors of cardiac survival in left ventricular systolic dysfunction
We, and others, have previously demonstrated that RVEF was an independent prognostic indicator in patients with LVSD.
1 -3,7 Abbreviations as in Table 1 .
These studies were, however, performed before the beta-blocker era. Our results are based on a cohort of patients who benefited from the recent improvements in heart failure management. Almost all of our patients received a combination of high doses of a beta-blocker with a renin inhibitor. In addition, new echoDoppler indices of RV systolic function have emerged and several studies have shown that they may provide prognostic information in heart failure patients. Tricuspid annular plane systolic excursion was the first RV echocardiographic parameter associated with survival in patients with LVSD. 8, 19 More recently, STr has emerged as a promising RV echoDoppler parameter for risk stratification. 17,20 -22 However, these studies have been performed in relatively small cohorts (from 40 to 170 patients) of patients with LVSD who rarely underwent a complete prognostic evaluation. Moreover, in contrast to most of the previous studies in which survival analyses were based on soft composite endpoints, 8, 20, 22 our study was focused on hard endpoints (cardiovascular death, urgent heart transplantation or LVAD) with .100 such events. One important new information is that RV systolic function remains an independent predictor of the outcome when adjusted for other well-known prognostic parameters such as aetiology, cardiac rhythm, presence of LBBB, 23, 24 LVEF, left atrial volume, increase estimated LV pressure, 25 BNP Figure 3 Survival curves of the study population according to cut-off values of right ventricular ejection fraction, tricuspid annular plane systolic excursion, and peak systolic tricuspid annular velocity.
Right ventricular systolic function and prognosis levels, and peak VO 2 . 26, 27 In contrast to a previous study by Ghio et al., 7 sPAP was not an independent predictor of cardiac survival.
Our data also provide information on the different RV parameters that can be used for risk stratification in patients with LVSD. Although RVEF, TAPSE, and STr were all associated with cardiac survival in univariate analyses, the results of our multivariate analyses demonstrated that RVEF remains the best RV prognostic parameter. There is, however, additive value of echocardiographic assessment as illustrated by the fact that the combination of RVEF with STr appeared in our hands as the best prognostic indicator for patients with LV systolic dysfunction.
Currently, some other new RV parameters, such as magnetic resonance imaging RVEF or RV strain rate, are being evaluated. 28, 29 Further studies are required in order to determine the best prognostic RV parameter for risk stratification in patients with LVSD.
Study limitations
Our study has a retrospective design but the risk of a selection bias was reduced by the inclusion of all our consecutive patients. Our study population represents a subgroup of patients with LVSD (young population of stable patients receiving optimal medical therapy). Thus, we cannot extend our results to other patients, particularly unstable patients. In these patients, RV echoDoppler parameters, which are easy to determine, are probably the most useful RV parameters for risk stratification. Similarly, in more severe patients it has been shown that invasive sPAP, in addition to RVEF, was a powerful independent predictor of outcome. We were not able to confirm this result since it was not ethical to perform to all our stable patients a right heart catheterization. However, estimated sPAP by echography was not an independent predictor of survival in our study population. The determination of RV parameters, but also all other prognostic parameters, were performed once. Serial determinations could bring possible new prognostic information. However, we demonstrated that in our patients, these parameters were reproducible. Right ventricular parameters were also determined at rest and a 'stress' evaluation Abbreviations as in Table 1 . a BNP Triage ≥280 pg/mL, BNP Advia Centaur ≥240 pg/mL (exercise, inotropes), looking at the RV contractility reserve, could be useful.
Conclusion
In the modern era of LVSD management, the evaluation of RV systolic function remains an important step for risk stratification. Although the advancement in echocardiography has led to the emergence of new easy indices of RV systolic function, such as TAPSE or STr, our study demonstrated in a large group of stable patients that radionuclide RVEF remains a powerful predictor for risk stratification. However, we also demonstrated that the combination of RVEF with STr improves risk stratification. We think that the results of the present study could help us for the selection of patients in whom heart transplantation or LVAD implantation need to be discussed. Right ventricular systolic function and prognosis
